To highlight the importance of vaccination, particularly against influenza and pneumococcus, in reducing respiratory infections and acute decompensations in heart failure patients.
Key Findings:
Vaccination is crucial in reducing respiratory infections and systemic inflammation in heart failure patients, with specific emphasis on influenza and pneumococcal vaccines.
Healthcare providers often lack awareness and engagement in vaccination efforts, leading to low vaccination rates, which significantly impact patient outcomes.
Respiratory infections are a primary cause of acute decompensation in heart failure patients, with a high incidence of pneumonia reported.
Interpretation:
The review underscores the need for improved awareness among healthcare providers regarding vaccination for heart failure patients to prevent respiratory infections and associated complications, emphasizing the role of specific vaccines.
Limitations:
Low vaccination rates among heart failure patients due to insufficient information from healthcare providers, which adversely affects patient outcomes.
Limited involvement of cardiologists in recommending vaccinations, contributing to low vaccination rates.
Conclusion:
Enhancing vaccination coverage, particularly for influenza and pneumococcus, in heart failure patients is essential to mitigate the risks of respiratory infections and improve overall patient outcomes.
by François Roubille, Nicolas Chapet, Camille Roubille, Marc Villacèque, Clément Delmas, Muriel Salvat, Frédéric Mouquet, Thibaud Damy, Jean-Michel Tartiere, Emmanuelle Berthelot, Peter Libby, Gianluigi Savarese, Paul Loubet, Nicolas Girerd
